BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7948756)

  • 1. Cervical cytology internal quality assurance--what are the national standards?
    Slater D
    Cytopathology; 1994 Aug; 5(4):207-10. PubMed ID: 7948756
    [No Abstract]   [Full Text] [Related]  

  • 2. Is proficiency testing in cervical cytology proficient?
    Herbert A
    J Clin Pathol; 1997 Jul; 50(7):536-7. PubMed ID: 9306928
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

  • 4. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'.
    Slater DN
    Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening.
    Faraker CA
    Cytopathology; 1993; 4(1):47-50. PubMed ID: 8453016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control assurance in national screening programmes for cervical cancer.
    Hadwin RJ; Walker PG
    Ann Acad Med Singap; 2003 Sep; 32(5):632-7. PubMed ID: 14626791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid-based cytology in cervical screening: a rapid and systematic review.
    Payne N; Chilcott J; McGoogan E
    Health Technol Assess; 2000; 4(18):1-73. PubMed ID: 10932023
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid review.
    Faraker CA
    Cytopathology; 1998 Apr; 9(2):71-6. PubMed ID: 9660635
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 13. Complaining about quality assurance in gynecologic cytology: a window that is now closing.
    Renshaw A
    Cancer; 2007 Jun; 111(3):141-2. PubMed ID: 17516436
    [No Abstract]   [Full Text] [Related]  

  • 14. State of the Art Symposium: prescreening and rescreening.
    O'Leary TJ
    Cancer; 2004 Dec; 102(6):331-3. PubMed ID: 15540232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal quality assurance of sensitivity of primary screening.
    Boxer ME
    Cytopathology; 1998 Oct; 9(5):349-50. PubMed ID: 9800134
    [No Abstract]   [Full Text] [Related]  

  • 16. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 18. External quality assessment in gynaecological cytology: The Trent Region experience. The Trent Regional Gynaecological Pathology Quality Assurance Group for the National Health Service Cervical Screening Programme.
    Slater DN; Hewer EM; Melling SE; Rice S
    Cytopathology; 2002 Aug; 13(4):206-19. PubMed ID: 12269893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to "access to cervical cancer screening: training internists so skill limitations are not a barrier to care".
    Savard M
    J Womens Health (Larchmt); 2007 Apr; 16(3):429. PubMed ID: 17439388
    [No Abstract]   [Full Text] [Related]  

  • 20. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
    Herbert A; Johnson J; Patnick J
    Cytopathology; 1995 Oct; 6(5):301-3. PubMed ID: 8785367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.